Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Progression”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT03716258
What this trial is testing

Characterizing Biomarkers of Early Parkinson's Disease Progression (TREG)

Who this might be right for
Parkinson DiseaseMovement Disorders
Oregon Health and Science University 16
Not applicableUnknownNCT04993274
What this trial is testing

Sensitivity of Motor Assessment in MS - a Prospective Cohort Study

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Secondary ProgressiveMultiple Sclerosis, Chronic Progressive
Friedemann Paul 100
Not applicableStudy completedNCT02013297
What this trial is testing

Study of SBRT Efficacy on Intra and Extra -Cranial Tumors or Metastasis in Pediatrics Population (SBRT Pediatrics)

Who this might be right for
Brain MetastasisSpinal TumorsLung Tumors+1 more
Centre Leon Berard 61
Testing effectiveness (Phase 2)Study completedNCT01077726
What this trial is testing

Xeloda (Capecitabine) in Breast Cancer Patients With Central Nervous System (CNS) Progression

Who this might be right for
Breast Cancer
Hoffmann-La Roche 3
Large-scale testing (Phase 3)UnknownNCT03594656
What this trial is testing

Effects of Lingzhi on Disease Progression in Patients With Untreated Early Parkinson's Disease

Who this might be right for
Parkinson Disease
Xuanwu Hospital, Beijing 288
Testing effectiveness (Phase 2)Study completedNCT00463203
What this trial is testing

Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy

Who this might be right for
Brain NeoplasmsGlioma
Rigshospitalet, Denmark 54
Not applicableStudy completedNCT02360137
What this trial is testing

Atherosclerotic Plaque Characteristics Associated With a Progression Rate of the Plaque in Carotids and a Risk of Stroke

Who this might be right for
Carotid Artery PlaqueCarotid Web
University Hospital Ostrava 1,863
Not applicableStudy completedNCT04349865
What this trial is testing

LRRK2 Activity and Markers of Parkinson's Disease in G2385R Carriers

Who this might be right for
Parkinson Disease
Xuanwu Hospital, Beijing 211
Not applicableUnknownNCT05451069
What this trial is testing

Neurofilament Light Chain ,Chitinase-3 Like-1 Proteins and Plasmacytoid Dendritic Cells in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Assiut University 42
Testing effectiveness (Phase 2)Study completedNCT01783756
What this trial is testing

Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis

Who this might be right for
Central Nervous System MetastasesHER2-positive Breast CancerMale Breast Cancer+2 more
Jonsson Comprehensive Cancer Center 9
Early research (Phase 1)Active Not RecruitingNCT05022147
What this trial is testing

Enhancing Gait Using Alternating-Frequency DBS in Parkinson Disease

Who this might be right for
Parkinson DiseaseGait Disorders, NeurologicDisease Progression+3 more
James Liao 12
Not applicableStudy completedNCT02574390
What this trial is testing

Answer ALS: Individualized Initiative for ALS Discovery

Who this might be right for
Amyotrophic Lateral SclerosisPrimary Lateral SclerosisFlail Arm ALS+5 more
Johns Hopkins University 1,049
Not applicableStudy completedNCT01604512
What this trial is testing

A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression

Who this might be right for
Brain Cancer
Memorial Sloan Kettering Cancer Center 148
Large-scale testing (Phase 3)Ended earlyNCT02430532
What this trial is testing

BG00012 and Delay of Disability Progression in Secondary Progressive Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Secondary Progressive
Biogen 58
Not applicableStudy completedNCT01112657
What this trial is testing

An Observational Study on the Progression of Clinically Isolated Syndrome to Multiple Sclerosis Over a 2-year Period

Who this might be right for
Multiple Sclerosis
Merck KGaA, Darmstadt, Germany 154
Not applicableStudy completedNCT05501431
What this trial is testing

Personalized Parkinson Project PSP Cohort

Who this might be right for
Progressive Supranuclear PalsyBrain DiseasesNeurodegenerative Diseases+1 more
Radboud University Medical Center 100
Not applicableActive Not RecruitingNCT07026929
What this trial is testing

Neuro-immune Interactome in Parkinson's Disease

Who this might be right for
Parkinson Disease
Yale University 94
Post-approval studies (Phase 4)Study completedNCT00147251
What this trial is testing

Stop Atherosclerosis in Native Diabetics Study

Who this might be right for
Cardiovascular DiseaseHypertensionHyperlipidemia+2 more
Cynthia West 548
Not applicableEnded earlyNCT01950910
What this trial is testing

Establishment of a Tissue Bank (Blood, CSF) for the Understanding of Motor Neuron Disease (MND)

Who this might be right for
Amyotrophic Lateral Sclerosis
Wake Forest University Health Sciences 766
Not applicableActive Not RecruitingNCT07448662
What this trial is testing

Local Treatment Strategies for Brain Metastases of Colorectal Cancer

Who this might be right for
Colorectal CancerBrain Metastases, Adult
Blokhin's Russian Cancer Research Center 700
Next Page